Market Closed -
Other stock markets
|
After market 16:00:01 | |||
12.2 EUR | -4.69% | 12.3 | +0.82% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 63% by 2026.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.79% | 550M | - | ||
-24.88% | 7.61B | C+ | ||
+7.04% | 6.63B | C- | ||
+15.10% | 5.53B | D+ | ||
-15.87% | 4.89B | B | ||
+14.96% | 4.17B | - | ||
-21.75% | 3.99B | B- | ||
-25.03% | 2.88B | C | ||
+44.01% | 2.38B | C- | ||
+1.98% | 2.08B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SIBN Stock
- 2K3 Stock
- Ratings SI-BONE, Inc.